Literature DB >> 15568526

Two mechanical devices for prophylaxis of thromboembolism after total knee arthroplasty. A prospective, randomised study.

P F Lachiewicz1, S S Kelley, L R Haden.   

Abstract

The optimal characteristics of pneumatic compression for mechanical prophylaxis of thromboembolism after total knee arthroplasty (TKA) are not known. Our study compared two methods of calf compression, with the hypothesis that the device which provided a larger increase in peak venous velocity would produce a lower rate of thromboembolism. We performed a prospective, randomised study on 423 patients (472 knees). Duplex ultrasonography was carried out by experienced technicians who were blinded to the device used. Overall, 206 patients (232 knees) used a rapid inflation, asymmetrical compression (RIAC) device and 217 (240 knees) a sequential circumferential compression device (SCD). The rate of venous thromboembolism was 6.9% with the RIAC device compared with 15% for the SCD device (p = 0.007). The incidence of thrombi with unilateral primary TKA was 8.4% for the RIAC compared with 16.8% for the SCD device (p = 0.03). In 47 patients with a bilateral TKA, the incidence of thrombi was 4% for the RIAC compared with 22.7% for the SCD device (p = 0.05 per knee). There was a low rate of mortality and pulmonary embolism when using mechanical prophylaxis for thromboembolism after TKA. Our findings show that the use of rapid inflation, asymmetrical calf compression gave a significantly lower rate of thromboembolism.

Entities:  

Mesh:

Year:  2004        PMID: 15568526     DOI: 10.1302/0301-620x.86b8.15438

Source DB:  PubMed          Journal:  J Bone Joint Surg Br        ISSN: 0301-620X


  8 in total

1.  Effects of intermittent pneumatic compression of the thigh on blood flow velocity in the femoral and popliteal veins: developing a new physical prophylaxis for deep vein thrombosis in patients with plaster-cast immobilization of the leg.

Authors:  Keisuke Nakanishi; Naonobu Takahira; Miki Sakamoto; Minako Yamaoka-Tojo; Masato Katagiri; Jun Kitagawa
Journal:  J Thromb Thrombolysis       Date:  2016-11       Impact factor: 2.300

2.  Pneumatic compression with foot pumps facilitates early postoperative mobilisation in total knee arthroplasty.

Authors:  C Windisch; W Kolb; K Kolb; P Grützner; R Venbrocks; J Anders
Journal:  Int Orthop       Date:  2010-07-22       Impact factor: 3.075

3.  Intense Triceps Surae Contraction Increases Lower Extremity Venous Blood Flow.

Authors:  Kouji Tsuda; Naonobu Takahira; Miki Sakamoto; Ato Shinkai; Kazuki Kaji; Jun Kitagawa
Journal:  Prog Rehabil Med       Date:  2017-07-05

4.  [Self-active physical thrombosis prophylaxis in the patients' bed with the Phlebostep: acceptance and measurement of venous blood flow in immobilized patients].

Authors:  L C Olivier; D Ostovan; W Heywinkel; D Kendoff; U Wolfhard
Journal:  Unfallchirurg       Date:  2007-11       Impact factor: 1.000

5.  Thromboprophylaxis and orthopaedic surgery: options and current guidelines.

Authors:  Gandhi Nathan Solayar; Fintan John Shannon
Journal:  Malays J Med Sci       Date:  2014-05

Review 6.  Potent anticoagulants are associated with a higher all-cause mortality rate after hip and knee arthroplasty.

Authors:  Nigel E Sharrock; Alejandro Gonzalez Della Valle; George Go; Stephen Lyman; Eduardo A Salvati
Journal:  Clin Orthop Relat Res       Date:  2008-02-10       Impact factor: 4.176

7.  Results of a Second-generation Constrained Condylar Prosthesis in Complex Primary and Revision Total Knee Arthroplasty: A Mean 5.5-Year Follow-up.

Authors:  Chen-Yi Ye; De-Ting Xue; Shuai Jiang; Rong-Xin He
Journal:  Chin Med J (Engl)       Date:  2016-06-05       Impact factor: 2.628

8.  Thigh-length graduated compression stocking cannot increase blood velocity of the common femoral vein in patients awaiting total hip arthroplasty.

Authors:  Tao Jiang; Kai Song; Yao Yao; Zaikai Zhuang; Ying Shen; Xinhua Li; Zhihong Xu; Qing Jiang
Journal:  BMC Musculoskelet Disord       Date:  2022-08-11       Impact factor: 2.562

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.